Integrating Psychotherapy and Pharmacotherapy: Dissolving the Mind-Brain Barrier (Norton Professional Books (Paperback)). Cet article n’est pas disponible.
Langue : anglais
Edité par W. W. Norton & Company, 2003
- Livre broché
- Occasion

Vendeur : HPB-Emerald, Dallas, TX, Etats-UnisHPB-Emerald
Vendeur AbeBooks depuis 15 septembre 2017
Etat: Occasion - Assez bon
EUR 9,16
A propos de cet article
Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority.
N° de réf. du vendeur S_461551458
- Titre
- Integrating Psychotherapy and Pharmacotherapy: Dissolving the Mind-Brain Barrier (Norton Professional Books (Paperback))
- Auteur
- Beitman M.D., Bernard D.,Blinder Ph.D., Barton J.,Thase M.D., Michael E.,Safer M.D., Debra L.
- Éditeur
- W. W. Norton & Company
- Année de publication
- 2003
- État de l'article
- Very Good
- Reliure
- paperback
- Langue
- anglais
- ISBN à 10 chiffres
- 0393704033
- ISBN à 13 chiffres
- 9780393704037
The authors of this book are searching for a language common to both mind and brain. This language will develop through innovative clinical activity and our reflections upon it.
This book will help all mental health clinicians to dissolve their conceptual mind/brain barriers by recognizing the reciprocal influences of psychological and pharmacological interventions. This task is approached by challenging the reader to respond to thought-provoking questions and problematic case vignettes in the following subject areas: combined treatment research, pharmacotherapy during psychotherapy, psychotherapy during pharmacotherapy, the pharmacotherapy-psychotherapy triangle and integrated treatment algorithms. Each of these homework-based sections is introduced by a brief overview. Part I invites the reader to an overview of these many issues. Topics covered include: 1) research in combined treatments, 2) pharmacotherapy during psychotherapy, 3) psychotherapeutic aspects of pharmacotherapy, 4) the pharmacotherapy-psychotherapy triangle, 5) treatment algorithms for combined treatments, and 6) the neurobiology of psychotherapy. With thought-provoking questions and vignettes of problematic cases, the authors invite readers to participate in working out these complicated issues. Part II provides cutting edge information on issues of integrated and split treatment and psychodynamic neurobiology. Answers to the problems are provided at the end of the book. Two additional chapters thoroughly review the research in combined treatments and what is known about the neurobiology of psychotherapy.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
À propos de l’auteur
Barton J. Blinder, M.D., Ph.D., is Clinical Professor, Director, Eating Disorder Research, Department of Psychiatry and Human Behavior, College of Medicine, University of California, Irvine.
Michael E. Thase, M.D., is Professor of Psychiatry, Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic.
Debra L. Safer, M.D., is Associate Director of Residency Training and Assistant Clinical Professor, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine.
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.